On the other hand, the calculated sensitivity is too low (56%) for the use of MALAT1 as a single biomarker for the diagnosis of NSCLC, particularly for the subtype AdCa (48%). The gene discussed is MALAT1; the disease is non-small cell lung carcinoma.